MARK M SIECZKAREK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK M SIECZKAREK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK M SIECZKAREK. MARK M SIECZKAREK is a President/CEO in CONCEPTUS INC ($CPTS) and a Director in Wize Pharma, Inc. ($WIZP) and a in NovaBay Pharmaceuticals, Inc. ($NBY) and a CEO in NovaBay Pharmaceuticals, Inc. ($NBY) and a Director in NovaBay Pharmaceuticals, Inc. ($NBY).
Address: 1021 HOWARD AVENUE SAN CARLOS 94070 CA
Companies in which MARK M SIECZKAREK is an Insider
CONCEPTUS INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MARK M SIECZKAREK: President/CEO
Holdings: 7,500 shares
Latest Transaction: Aug 10 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mawson Infrastructure Group Inc.
Industry: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
Position of MARK M SIECZKAREK: Director
Holdings: 0 shares
Latest Transaction: Aug 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NovaBay Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK M SIECZKAREK: Director
Holdings: 1,156,883 shares
Current Value: $4,569,688
Latest Transaction: Oct 28 2019
$NBY Market Capitalization: $61.37M
$NBY Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MARK M SIECZKAREK
Sentiment: All, CPTS, WIZP, NBY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13 2020 | WIZP | Wize Pharma, Inc. | SIECZKAREK MARK M | Director | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
| Oct 28 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
| Aug 06 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Grant | A | 0.00 | 167,938 | 0 | 1,156,883 | 988.9 K to 1.2 M (+16.98 %) | |
| Jun 06 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 2.35 | 250,000 | 587,500 | 250,000 | |
| Jan 26 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 3.60 | 238,609 | 858,992 | 936,857 | |
| Oct 03 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Buy | X | 1.91 | 273,447 | 522,284 | 988,945 | 715.5 K to 988.9 K (+38.22 %) |
| Aug 02 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 1.91 | 130,890 | 250,000 | 273,447 |